CAN WE PREVENT END-STAGE RENAL-DISEASE DUE TO HYPERTENSION OR TO DIABETES-MELLITUS

被引:9
作者
LUKE, RG
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1992年 / 268卷 / 21期
关键词
D O I
10.1001/jama.268.21.3119
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3119 / 3120
页数:2
相关论文
共 12 条
  • [1] THE EXCESS INCIDENCE OF DIABETIC END-STAGE RENAL-DISEASE AMONG BLACKS - A POPULATION-BASED STUDY OF POTENTIAL EXPLANATORY FACTORS
    BRANCATI, FL
    WHITTLE, JC
    WHELTON, PK
    SEIDLER, AJ
    KLAG, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (21): : 3079 - 3084
  • [2] SCREENING FOR HYPERTENSION
    LITTENBERG, B
    GARBER, AM
    SOX, HC
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (03) : 192 - 202
  • [3] LUKE RG, 1991, HYPERTENSION S3, V18, P1139
  • [4] QUALHEIM RD, 1991, AM J KIDNEY DIS, V18, P335
  • [5] HYPERTENSION AS A DISEASE OF CARBOHYDRATE AND LIPOPROTEIN METABOLISM
    REAVEN, GM
    HOFFMAN, BB
    [J]. AMERICAN JOURNAL OF MEDICINE, 1989, 87 (6A) : S2 - S6
  • [6] RACIAL-DIFFERENCES IN THE INCIDENCE OF TREATMENT FOR END-STAGE RENAL-DISEASE
    ROSTAND, SG
    KIRK, KA
    RUTSKY, EA
    PATE, BA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (21) : 1276 - 1279
  • [7] A COMPARISON OF THE EFFICACY AND SAFETY OF A BETA-BLOCKER, A CALCIUM-CHANNEL BLOCKER, AND A CONVERTING-ENZYME-INHIBITOR IN HYPERTENSIVE BLACKS
    SAUNDERS, E
    WEIR, MR
    KONG, BW
    HOLLIFIELD, J
    GRAY, J
    VERTES, V
    SOWERS, JR
    ZEMEL, MB
    CURRY, C
    SCHOENBERGER, J
    WRIGHT, JT
    KIRKENDALL, W
    CONRADI, EC
    JENKINS, P
    MCLEAN, B
    MASSIE, B
    BERENSON, G
    FLAMENBAUM, W
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (08) : 1707 - 1713
  • [8] FAMILIAL CLUSTERING OF DIABETIC KIDNEY-DISEASE - EVIDENCE FOR GENETIC SUSCEPTIBILITY TO DIABETIC NEPHROPATHY
    SEAQUIST, ER
    GOETZ, FC
    RICH, S
    BARBOSA, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) : 1161 - 1165
  • [9] RENAL-FUNCTION CHANGE IN HYPERTENSIVE MEMBERS OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL - RACIAL AND TREATMENT EFFECTS
    WALKER, WG
    NEATON, JD
    CUTLER, JA
    NEUWIRTH, R
    COHEN, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (21): : 3085 - 3091
  • [10] DOES RACIAL VARIATION IN RISK-FACTORS EXPLAIN BLACK-WHITE DIFFERENCES IN THE INCIDENCE OF HYPERTENSIVE END-STAGE RENAL-DISEASE
    WHITTLE, JC
    WHELTON, PK
    SEIDLER, AJ
    KLAG, MJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (07) : 1359 - 1364